Clinical trialObservationalWithdrawn
Medication Adherence and Non-adherence in Adults With Rare Disease
A Longitudinal, Digital Study Using the Medication Adherence Reasons Scale (MAR-Scale) to Identify the Reasons for Non-adherence to Medications in Rare Disease
- Outcome
- Stopped earlyLiquidation of sponsor (Business decision)
- Phase
- Observational
- Status
- Withdrawn
- Study type
- Observational
- Planned start
- January 2021
- Planned end
- September 2022
- Enrollment
- 0 participants
- Sites
- 0
- Primary outcomes
- To use the MAR-Scale to determine the extent of non-adherence to specific medications indicated to treat a range of rare diseases.; To use the MAR-Scale to determine the extent of non-adherence to specific medications indicated to treat a range of rare diseases.; To use the MAR-Scale to determine the extent of non-adherence to specific medications indicated to treat a range of rare diseases.; To use the MAR-Scale to determine the extent of non-adherence to specific medications indicated to treat a range of rare diseases.; To use the MAR-Scale to determine the extent of non-adherence to specific medications indicated to treat a range of rare diseases.
- Sponsor type
- Academic / other
- Results posted
- No
- Last update
- 12 May 2022
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The purpose of this study is to use the Medication Adherence Reasons Scale (MAR-Scale) to determine the extent of non-adherence to specific medications indicated to treat cystic fibrosis, hemophilia (A or B), idiopathic pulmonary fibrosis, myasthenia gravis, and sickle cell disease, and to identify the top patient-reported reasons for non-adherence. Internal reliability of the MAR-Scale will also be assessed in each condition.